Michiel de Jong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Michiel de Jong has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Bert F. Bernard
Erasmus MC
3 shared publicationsE. van der Kolk
3 shared publicationsEric P. Krenning
Erasmus MC
3 shared publicationsArthur Van Gameren
Erasmus MC
1 shared publication- Astrid Capello
Department of Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
1 shared publication - Berthold Artur Nock
Molecular Radiopharmacy, INRASTES, NCSR “Demokritos”, 15341 Athens, Greece
1 shared publication
Latest Publications
- Open Access
- 2 October 2019
- Published by Taylor & Francis in New Review of Academic Librarianship
- Vol. 25 (2-4) , 392-407
Innovation Opportunities for Academic Libraries to Support Teaching Through Open Education: A Case Study at TU Delft, The Netherlands
Opportunities are presented for academic libraries to enrich their products and services through facilitating open education in higher education, in an overview of good practices. A case study of open textbook publishing was performed at TU Delft to study how these products and services could stimulate educators to adopt open education. A simplified user acceptance model of innovation was developed and applied to the case study, to study the educator’s mind-set before and after they published an open textbook with the support of the TU Delft Library. Using the insights that were gained from the case study and from good practices of other university libraries, recommendations are presented for professionalizing products and services by academic libraries to facilitate the adoption of open education into the educational practice and to develop institutional policies and regulations that support educators with these practices.
- 2 October 2019
- Published by Taylor & Francis in New Review of Academic Librarianship
- Vol. 25 (2-4) , 392-407
Open AccessInnovation Opportunities for Academic Libraries to Support Teaching Through Open Education: A Case Study at TU Delft, The Netherlands
Opportunities are presented for academic libraries to enrich their products and services through facilitating open education in higher education, in an overview of good practices. A case study of open textbook publishing was performed at TU Delft to study how these products and services could stimulate educators to adopt open education. A simplified user acceptance model of innovation was developed and applied to the case study, to study the educator’s mind-set before and after they published an open textbook with the support of the TU Delft Library. Using the insights that were gained from the case study and from good practices of other university libraries, recommendations are presented for professionalizing products and services by academic libraries to facilitate the adoption of open education into the educational practice and to develop institutional policies and regulations that support educators with these practices.
- 1 March 2016
- Published by Elsevier in Thin Solid Films
- Vol. 603, 342-347
Oxidation and crystallization behavior of calcium europium silicon nitride thin films during rapid thermal processing
- 1 March 2016
- Published by Elsevier in Thin Solid Films
- Vol. 603, 342-347
Oxidation and crystallization behavior of calcium europium silicon nitride thin films during rapid thermal processing
- 1 August 2015
- Published by Elsevier in Optical Materials
- Vol. 46, 149-153
Deposition of luminescent NaCl:Tm2+ thin films with a Tm concentration gradient using RF magnetron sputtering
- 1 August 2015
- Published by Elsevier in Optical Materials
- Vol. 46, 149-153
Deposition of luminescent NaCl:Tm2+ thin films with a Tm concentration gradient using RF magnetron sputtering
- 1 August 2015
- Published by Elsevier in Journal of Luminescence
- Vol. 164, 52-56
DC/RF magnetron sputter deposition and characterisation of Ca3Si2N2O4:Eu2+ luminescent thin films
- 1 August 2015
- Published by Elsevier in Journal of Luminescence
- Vol. 164, 52-56
DC/RF magnetron sputter deposition and characterisation of Ca3Si2N2O4:Eu2+ luminescent thin films
- Open Access
Business Rule Mining from Spreadsheets
Business rules represent the knowledge that guides the operations of a business organization. They are implemented in software applications used by organizations, and the activity of extracting them from software is known as business rule mining. It has various purposes amongst which migration and generating documentation are the most common. However, apart from conventional software, organizations also use spreadsheets for a large part of their operations and decision-making activities. Therefore we believe that spreadsheets are also rich in business rules. We thus propose to develop an automated system for extracting business rules from spreadsheets in a human comprehensible natural language format. This position paper describes our motivation, the problem description, related work, and challenges we foresee.
Open AccessBusiness Rule Mining from Spreadsheets
Business rules represent the knowledge that guides the operations of a business organization. They are implemented in software applications used by organizations, and the activity of extracting them from software is known as business rule mining. It has various purposes amongst which migration and generating documentation are the most common. However, apart from conventional software, organizations also use spreadsheets for a large part of their operations and decision-making activities. Therefore we believe that spreadsheets are also rich in business rules. We thus propose to develop an automated system for extracting business rules from spreadsheets in a human comprehensible natural language format. This position paper describes our motivation, the problem description, related work, and challenges we foresee.
- 23 August 2013
- Published by AIP Publishing in Journal of Applied Physics
- Vol. 114 (8) , 084502
Efficiency enhancement calculations of state-of-the-art solar cells by luminescent layers with spectral shifting, quantum cutting, and quantum tripling function
Solar cells of which the efficiency is not limited by the Shockley-Queisser limit can be obtained by integrating a luminescent spectral conversion layer into the cell structure. We have calculated the maximum efficiency of state-of-the-art c-Si, pc-Si, a-Si, CdTe, GaAs, CIS, CIGS, CGS, GaSb, and Ge solar cells with and without an integrated spectral shifting, quantum cutting, or quantum tripling layer using their measured internal quantum efficiency (IQE) curves. Our detailed balance limit calculations not only take into account light in-coupling efficiency of the direct AM1.5 spectral irradiance but also wavelength dependence of the refractive index and the IQEs of the cells and the angular dependent light in-coupling of the indirect spectral irradiance. An ideal quantum cutting layer enhances all cell efficiencies ranging from a modest 2.9% for c-Si to much larger values of 4.0%, 7.7%, and 11.2% for CIGS, Ge, and GaSb, respectively. A quantum tripling layer also enhances cell efficiencies, but to a lesser extent. These efficiency enhancements are largest for small band gap cells like GaSb (7.5%) and Ge (3.8%). Combining a quantum tripling and a quantum cutting layer would enhance efficiency of these cells by a factor of two. Efficiency enhancement by a simple spectral shifting layer is limited to less than 1% in case the IQE is high for blue and UV lights. However, for CdTe and GaSb solar cells, efficiency enhancements are as high as 4.6% and 3.5%, respectively. A shifting layer based on available red LED phosphors like Sr2Si5N8:Eu will raise CdTe efficiency by 3.0%.
- 23 August 2013
- Published by AIP Publishing in Journal of Applied Physics
- Vol. 114 (8) , 084502
Efficiency enhancement calculations of state-of-the-art solar cells by luminescent layers with spectral shifting, quantum cutting, and quantum tripling function
Solar cells of which the efficiency is not limited by the Shockley-Queisser limit can be obtained by integrating a luminescent spectral conversion layer into the cell structure. We have calculated the maximum efficiency of state-of-the-art c-Si, pc-Si, a-Si, CdTe, GaAs, CIS, CIGS, CGS, GaSb, and Ge solar cells with and without an integrated spectral shifting, quantum cutting, or quantum tripling layer using their measured internal quantum efficiency (IQE) curves. Our detailed balance limit calculations not only take into account light in-coupling efficiency of the direct AM1.5 spectral irradiance but also wavelength dependence of the refractive index and the IQEs of the cells and the angular dependent light in-coupling of the indirect spectral irradiance. An ideal quantum cutting layer enhances all cell efficiencies ranging from a modest 2.9% for c-Si to much larger values of 4.0%, 7.7%, and 11.2% for CIGS, Ge, and GaSb, respectively. A quantum tripling layer also enhances cell efficiencies, but to a lesser extent. These efficiency enhancements are largest for small band gap cells like GaSb (7.5%) and Ge (3.8%). Combining a quantum tripling and a quantum cutting layer would enhance efficiency of these cells by a factor of two. Efficiency enhancement by a simple spectral shifting layer is limited to less than 1% in case the IQE is high for blue and UV lights. However, for CdTe and GaSb solar cells, efficiency enhancements are as high as 4.6% and 3.5%, respectively. A shifting layer based on available red LED phosphors like Sr2Si5N8:Eu will raise CdTe efficiency by 3.0%.
- 28 March 2006
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 33 (7) , 831-840
[99mTc]Demotate 2 in the detection of sst2-positive tumours: a preclinical comparison with [111In]DOTA-tate
The aim of this study was to evaluate [99mTc]Demotate 2 ([99mTc-N40-1,Asp0,Tyr3]octreotate) as a candidate for in vivo imaging of sst2-positive tumours and to compare it with [111In]DOTA-tate ([111In-DOTA0,Tyr3]octreotate). Labelling of Demotate 2 with 99mTc was performed at room temperature using SnCl2 as reductant in the presence of citrate at alkaline pH. Radiochemical analysis involved ITLC and HPLC methods. Peptide conjugate affinities for sst2 were determined by receptor autoradiography on rat brain cortex sections using [DOTA0,125I-Tyr3]octreotate as the radioligand. The affinity profile of Demotate 2 for human sst1–sst5 was studied by receptor autoradiography in cell preparations using the universal somatostatin radioligand [125I][Leu8,(D)Trp22,Tyr25]somatostatin-28. The internalisation rates of [99mTc]Demotate 2 and [111In]DOTA-tate were compared in sst2-positive and -negative control cell lines. Biodistribution of radiopeptides was studied in male Lewis rats bearing CA20948 tumours. Peptide conjugates showed selectivity and a high affinity binding for sst2 (Demotate 2 IC50=3.2 nM and DOTA-tate IC50=5.4 nM). [99mTc]Demotate 2, like [111In]DOTA-tate, internalised rapidly in all sst2-positive cells tested, but not in sst2-negative control cells. After injection in CA20948 tumour-bearing rats both radiopeptides showed high and specific uptake in the sst2-positive organs and in the implanted tumour and rapid excretion from non-target tissues via the kidneys. [99mTc]Demotate 2, similarly to the known sst2-targeting agent [111In]DOTA-tate, showed promising biological qualities for application in the scintigraphy of sst2-positive tumours.
- 28 March 2006
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 33 (7) , 831-840
[99mTc]Demotate 2 in the detection of sst2-positive tumours: a preclinical comparison with [111In]DOTA-tate
The aim of this study was to evaluate [99mTc]Demotate 2 ([99mTc-N40-1,Asp0,Tyr3]octreotate) as a candidate for in vivo imaging of sst2-positive tumours and to compare it with [111In]DOTA-tate ([111In-DOTA0,Tyr3]octreotate). Labelling of Demotate 2 with 99mTc was performed at room temperature using SnCl2 as reductant in the presence of citrate at alkaline pH. Radiochemical analysis involved ITLC and HPLC methods. Peptide conjugate affinities for sst2 were determined by receptor autoradiography on rat brain cortex sections using [DOTA0,125I-Tyr3]octreotate as the radioligand. The affinity profile of Demotate 2 for human sst1–sst5 was studied by receptor autoradiography in cell preparations using the universal somatostatin radioligand [125I][Leu8,(D)Trp22,Tyr25]somatostatin-28. The internalisation rates of [99mTc]Demotate 2 and [111In]DOTA-tate were compared in sst2-positive and -negative control cell lines. Biodistribution of radiopeptides was studied in male Lewis rats bearing CA20948 tumours. Peptide conjugates showed selectivity and a high affinity binding for sst2 (Demotate 2 IC50=3.2 nM and DOTA-tate IC50=5.4 nM). [99mTc]Demotate 2, like [111In]DOTA-tate, internalised rapidly in all sst2-positive cells tested, but not in sst2-negative control cells. After injection in CA20948 tumour-bearing rats both radiopeptides showed high and specific uptake in the sst2-positive organs and in the implanted tumour and rapid excretion from non-target tissues via the kidneys. [99mTc]Demotate 2, similarly to the known sst2-targeting agent [111In]DOTA-tate, showed promising biological qualities for application in the scintigraphy of sst2-positive tumours.
- 1 August 2004
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 31 (6) , 821-824
Reduction of skeletal accumulation of radioactivity by co-injection of DTPA in [90Y-DOTA0,Tyr3]octreotide solutions containing free 90Y3+
- 1 August 2004
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 31 (6) , 821-824
Reduction of skeletal accumulation of radioactivity by co-injection of DTPA in [90Y-DOTA0,Tyr3]octreotide solutions containing free 90Y3+
- 1 October 2003
- Published by SAGE Publications in Cancer Biotherapy and Radiopharmaceuticals
- Vol. 18 (5) , 761-768
Tyr 3 -Octreotide and Tyr 3 -Octreotate Radiolabeled with 177 Lu or 90 Y: Peptide Receptor Radionuclide Therapy Results In Vitro
Somatostatin analogs promising for peptide receptor scintigraphy (PRS) and peptide receptor radionuclide therapy (PRRT) are D-Phe-c(Cys-Tyr-D-Trp-Lys-Thr-Cys)-Thr(ol) (Tyr 3-octreotide) and D-Phe-c(Cys-Tyr-D-Trp-Lys-Thr-Cys)-Thr (tyr3-octreotate). For radiotherapeutic applications these peptides are being labeled with the β- particle emitters 177Lu or 90Y. We evaluated the therapeutic effects of these analogs chelated with tetra-azacyclododecatatro-acetic acid (DOTA) and labeled with 90Y or 177Lu in an in vitro colony-forming assay using the rat pancreatic tumor cell line CA20948. Furthermore, we investigated the effects of incubation time, radiation dose, and specific activity of [177Lu-DOTA]-D-Phe1-c (Cys-Tyr-D-Trp-Lys-Thr-Cys)-Thr (177Lu-octreotate). 177Lu-octreotate could reduce tumor growth to 100% cell kill and effects were dependent on radiation dose, incubation time, and specific activity used. Similar concentrations of 177Lu-DOTA, which is not bound to the cells, had a less pronounced effect on the tumor cell survival. Both tyr3-octreotide and tyr3-octreotate labeled with either 177Lu or 90Y, using DOTA as chelator, were able to control tumor growth in a dose-dependent manner. In all concentrations used radiolabeled tyr3-octreotate had a higher tumor kill compared to radiolabeled tyr3-octreotide, labeled with 177Lu or 90Y. This is in accordance with the higher affinity of tyr3-octreotate for the subtype 2 (sst2)-receptor compared to tyr3-octreotide, leading to a higher amount of cell-associated radioactivity, resulting in a significantly higher tumor radiation dose. In conclusion, tyr3-octreotate labeled with 177Lu or 90Y is the most promising analog for PRRT.
- 1 October 2003
- Published by SAGE Publications in Cancer Biotherapy and Radiopharmaceuticals
- Vol. 18 (5) , 761-768
Tyr 3 -Octreotide and Tyr 3 -Octreotate Radiolabeled with 177 Lu or 90 Y: Peptide Receptor Radionuclide Therapy Results In Vitro
Somatostatin analogs promising for peptide receptor scintigraphy (PRS) and peptide receptor radionuclide therapy (PRRT) are D-Phe-c(Cys-Tyr-D-Trp-Lys-Thr-Cys)-Thr(ol) (Tyr 3-octreotide) and D-Phe-c(Cys-Tyr-D-Trp-Lys-Thr-Cys)-Thr (tyr3-octreotate). For radiotherapeutic applications these peptides are being labeled with the β- particle emitters 177Lu or 90Y. We evaluated the therapeutic effects of these analogs chelated with tetra-azacyclododecatatro-acetic acid (DOTA) and labeled with 90Y or 177Lu in an in vitro colony-forming assay using the rat pancreatic tumor cell line CA20948. Furthermore, we investigated the effects of incubation time, radiation dose, and specific activity of [177Lu-DOTA]-D-Phe1-c (Cys-Tyr-D-Trp-Lys-Thr-Cys)-Thr (177Lu-octreotate). 177Lu-octreotate could reduce tumor growth to 100% cell kill and effects were dependent on radiation dose, incubation time, and specific activity used. Similar concentrations of 177Lu-DOTA, which is not bound to the cells, had a less pronounced effect on the tumor cell survival. Both tyr3-octreotide and tyr3-octreotate labeled with either 177Lu or 90Y, using DOTA as chelator, were able to control tumor growth in a dose-dependent manner. In all concentrations used radiolabeled tyr3-octreotate had a higher tumor kill compared to radiolabeled tyr3-octreotide, labeled with 177Lu or 90Y. This is in accordance with the higher affinity of tyr3-octreotate for the subtype 2 (sst2)-receptor compared to tyr3-octreotide, leading to a higher amount of cell-associated radioactivity, resulting in a significantly higher tumor radiation dose. In conclusion, tyr3-octreotate labeled with 177Lu or 90Y is the most promising analog for PRRT.